Skip to main content
An official website of the United States government

Publications from the Nanotechnology Characterization Lab

Recent Publications 

 

Special Issue "Nanotechnology to Overcome the World's Most Critical Health Issues: Liposomes and Beyond-A Themed Issue Dedicated to Professor Yechezkel Barenholz".
Dobrovolskaia MA, Afonin KA.
Molecules. 2023; 28 (12): 4788. [PubMed Abstract]

Detection of Nanoparticles' Ability to Stimulate Toll-Like Receptors Using HEK-Blue Reporter Cell Lines.
Cedrone E, Dobrovolskaia MA.
Methods Mol Biol. 2023; 2709: 241-251. [PubMed Abstract]

Multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles.
Newton HS, Zhang J, Donohue D, Unnithan R, Cedrone E, Xu J, Vermilya A, Malys T, Clogston JD, and Dobrovolskaia MA.
Front Allergy. 2023; 4: 1126012. [PubMed Abstract]

Change in Lipofectamine Carrier as a Tool to Fine-Tune Immunostimulation of Nucleic Acid Nanoparticles.
Newton HS, Radwan Y, Xu J, Clogston JD, Dobrovolskaia MA, and Afonin KA.
Molecules. 2023; 28(11): 4484. [PubMed Abstract]

Evaluation of nonmodified wireframe DNA origami for acute toxicity and biodistribution in mice.
Wamhoff EC, Knappe GA, Burds AA, Du RR, Neun BW, Difilippantonio S, Sanders C, Edmondson EF, Matta JL, Dobrovolskaia MA, Bathe M.
ACS Appl Bio Mater. 2023; 6(5): 1960-1969. [PubMed Abstract]

Plasma stability and plasma metabolite concentration-time profiles of oligo(lactic acid)(8)-paclitaxel prodrug loaded polymeric micelles.
Repp L, Skoczen SL, Rasoulianboroujeni M, Stern ST, Kwon GS. 
AAPS J. 2023; 25(3): 39. [PubMed Abstract]

Target-specific nanoparticle polyplex down-regulates mutant Kras to prevent pancreatic carcinogenesis and halt tumor progression.
Smith JP, Chen W, Shivapurkar N, Gerber M, Tucker RD, Kallakury B, Dasa SSK, Kularatne RN, Stern ST. 
Int J Mol Sci. 2023; 24(1): 752. [PubMed Abstract]

Nanocomplexes of doxorubicin and DNA fragments for efficient and safe cancer chemotherapy.
Mohammad SN, Choi YS, Chung JY, Cedrone E, Neun BW, Dobrovolskaia MA, Yang X, Guo W, Chew YC, Kim J, Baek S, Kim IS, Fruman DA, Kwon YJ.
J Control Release. 2023; 354: 91-108. [PubMed Abstract]

 

 

For a more comprehensive list of NCL publications, visit our Web of Science bibliography page.

 

  • Reviewed:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Publications from the Nanotechnology Characterization Lab was originally published by the National Cancer Institute.”

Email